XML 51 R44.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stockholders' Equity - Additional Information (Detail)
1 Months Ended 6 Months Ended
Aug. 15, 2023
USD ($)
shares
Sep. 27, 2022
USD ($)
$ / shares
shares
Apr. 06, 2022
USD ($)
$ / shares
shares
Oct. 18, 2021
USD ($)
PrivatePlacement
$ / shares
shares
Oct. 05, 2021
USD ($)
$ / shares
shares
Feb. 29, 2024
shares
Jun. 30, 2023
USD ($)
May 31, 2022
USD ($)
Oct. 31, 2021
PrivatePlacement
Jun. 30, 2020
USD ($)
Jun. 30, 2024
USD ($)
shares
Stockholders Equity [Line Items]                      
Share based compensation options grants in the period                     2,846,750
Performance-Based Vesting Stock Options [Member]                      
Stockholders Equity [Line Items]                      
Share based compensation options grants in the period           832,250          
Private Placement [Member]                      
Stockholders Equity [Line Items]                      
Number of private placements | PrivatePlacement                 2    
Private Placement [Member] | Investor [Member]                      
Stockholders Equity [Line Items]                      
Warrants to purchase aggregate shares of common stock         9,852,138            
Warrants Exercised         1,299,270            
Warrants expiration date         Oct. 05, 2028            
Private Placement [Member] | Investor [Member] | Common Stock [Member]                      
Stockholders Equity [Line Items]                      
Sale of stock during the period         2,373,201            
Warrants to purchase aggregate shares of common stock         4,746,402            
Private Placement [Member] | Investor [Member] | Pre-funded Warrants [Member]                      
Stockholders Equity [Line Items]                      
Exercise price per share of warrants | $ / shares         $ 0.001            
Private Placement [Member] | Investor [Member] | Common Stock and Accompanying Common Stock Warrants [Member]                      
Stockholders Equity [Line Items]                      
Combined price of each shares | $ / shares         1.62            
Private Placement [Member] | Investor [Member] | Pre-funded Warrant and Accompanying Common Stock Warrants [Member]                      
Stockholders Equity [Line Items]                      
Combined price of each shares | $ / shares         $ 1.619            
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs | $         $ 11,800,000            
Private Placement [Member] | Investor [Member] | Common Stock Warrants                      
Stockholders Equity [Line Items]                      
Warrants to purchase aggregate shares of common stock         7,299,270            
Exercise price per share of warrants | $ / shares         $ 1.37            
Warrants expiration date         Apr. 05, 2025            
Private Placement [Member] | Investor [Member] | Warrant [Member]                      
Stockholders Equity [Line Items]                      
Warrants to purchase aggregate shares of common stock         7,299,270            
Warrants expiration date         Oct. 05, 2028            
Private Placement [Member] | New Enterprise Associates 16, L.P [Member]                      
Stockholders Equity [Line Items]                      
Warrants to purchase aggregate shares of common stock       3,703,704              
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs | $       $ 13,700,000              
Number of private placements | PrivatePlacement       2              
Proceeds from issuance of private placement net of issuance costs | $       $ 1,100,000              
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Common Stock [Member]                      
Stockholders Equity [Line Items]                      
Sale of stock during the period       1,851,852              
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Common Stock and Accompanying Common Stock Warrants [Member]                      
Stockholders Equity [Line Items]                      
Common stock warrants exercise price and expiration date description                     The accompanying common stock warrants have an exercise price of $1.37 per share and became exercisable immediately upon issuance. Of the accompanying common stock warrants, warrants to purchase an aggregate of 1,851,852 shares of the Company’s common stock will expire on April 18, 2025, and warrants to purchase an aggregate of 1,851,852 shares of the Company’s common stock will expire on October 18, 2028. None of the accompanying common stock warrants issued to NEA in the private placement have been exercised.
Combined price of each shares | $ / shares       $ 1.62              
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs | $       $ 3,000,000              
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Common Stock Warrants                      
Stockholders Equity [Line Items]                      
Warrants to purchase aggregate shares of common stock       1,851,852              
Exercise price per share of warrants | $ / shares       $ 1.37              
Warrants expiration date       Apr. 18, 2025              
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Warrant [Member]                      
Stockholders Equity [Line Items]                      
Warrants to purchase aggregate shares of common stock       1,851,852              
Warrants expiration date       Oct. 18, 2028              
Private Placement [Member] | Securities Purchase Agreement [Member] | Common Stock [Member]                      
Stockholders Equity [Line Items]                      
Sale of stock during the period     4,580,526                
Combined price of each shares | $ / shares     $ 1.90                
Private Placement [Member] | Securities Purchase Agreement [Member] | Pre-funded Warrants [Member]                      
Stockholders Equity [Line Items]                      
Combined price of each shares | $ / shares     $ 1.899                
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs | $     $ 55,000,000                
Exercise price per share of warrants | $ / shares     $ 0.001                
September 2022 Offering [Member] | Underwriting Agreement [Member]                      
Stockholders Equity [Line Items]                      
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs | $   $ 58,100,000                  
Warrants expiration date   Sep. 27, 2022                  
September 2022 Offering [Member] | Underwriting Agreement [Member] | Common Stock [Member]                      
Stockholders Equity [Line Items]                      
Sale of stock during the period   14,252,670                  
Combined price of each shares | $ / shares   $ 1.93                  
Exercise price per share of warrants | $ / shares   $ 0.001                  
September 2022 Offering [Member] | Underwriting Agreement [Member] | Pre-funded Warrants [Member]                      
Stockholders Equity [Line Items]                      
Warrants to purchase aggregate shares of common stock   14,247,330                  
Combined price of each shares | $ / shares   $ 1.929                  
Options to purchase additional shares   1,600,428                  
Maximum [Member] | Private Placement [Member] | Investor [Member] | Pre-funded Warrants [Member]                      
Stockholders Equity [Line Items]                      
Warrants to purchase aggregate shares of common stock         4,926,069            
Maximum [Member] | Private Placement [Member] | Securities Purchase Agreement [Member] | Pre-funded Warrants [Member]                      
Stockholders Equity [Line Items]                      
Warrants to purchase aggregate shares of common stock     24,379,673                
Maximum [Member] | September 2022 Offering [Member] | Underwriting Agreement [Member] | Pre-funded Warrants [Member]                      
Stockholders Equity [Line Items]                      
Warrants to purchase aggregate shares of common stock   4,275,000                  
ATM Sales Agreement [Member]                      
Stockholders Equity [Line Items]                      
Aggregate offering price of common stock which may issue and sell under agreement | $             $ 75,000,000 $ 50,000,000   $ 12,000,000 $ 62,000,000
Sale of stock during the period 4,333,394                   1,474,926
Proceeds from issuance of common stock | $ $ 12,700,000                   $ 5,000,000
Estimated commissions and allocated fees | $ $ 1,000,000                   $ 200,000
Proceeds from issuance of common stock, preferred stock, debt securities, units and or warrants | $             $ 200,000,000